BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28057086)

  • 1. Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease.
    Yu ZH; Wang HT; Tu C
    Eur J Med Res; 2017 Jan; 22(1):2. PubMed ID: 28057086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of Circulating microRNAs for In-Stent Restenosis in Patients with Lower Extremity Arterial Occlusive Disease.
    Yuan L; Dong J; Zhu G; Bao J; Lu Q; Zhou J; Jing Z
    Sci Rep; 2019 Feb; 9(1):1402. PubMed ID: 30718561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease.
    Zhang B; Yao Y; Sun QF; Liu SQ; Jing B; Yuan C; Liu XY; Jiao T; Li HC; Wang HY
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28250135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K; Li YJ; Gao S
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
    Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of miRNA-1,miRNA-21 in plasma on in-stent restenosis in patients with coronary heart disease and diabetes mellitus after percutaneous coronary intervention].
    Guan JJ; Zhang Y; Liu YJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Apr; 34(4):304-308 384. PubMed ID: 30788936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case-control study.
    Pan CH; Chien SC; Chen CJ; Shih CM; Hsieh MH; Huang CY; Bi WF; Chan CS; Kao YT; Hsiao CY; Chiang SJ; Chiang KH; Huang JH; Liu YR; Luo JD; Huang HY; Wu CH
    BMC Cardiovasc Disord; 2021 Feb; 21(1):77. PubMed ID: 33557763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
    Turak O; Canpolat U; Özcan F; Mendi MA; Oksüz F; Işleyen A; Gürel OM; Çay S; Aras D; Aydoğdu S
    Am J Cardiol; 2014 Jan; 113(2):197-202. PubMed ID: 24157191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis.
    He M; Gong Y; Shi J; Pan Z; Zou H; Sun D; Tu X; Tan X; Li J; Li W; Liu B; Xue J; Sheng L; Xiu C; Yang N; Xue H; Ding X; Yu C; Li Y
    PLoS One; 2014; 9(11):e112043. PubMed ID: 25427155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentially expressed miR-152, a potential biomarker for in-stent restenosis (ISR) in peripheral blood mononuclear cells (PBMCs) of coronary artery disease (CAD) patients.
    Maheronnaghsh M; Niktab I; Enayati S; Amoli MM; Hosseini SK; Tavakkoly-Bazzaz J
    Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1137-1147. PubMed ID: 33712363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of 64-slice multidetector CT angiography for detection of in-stent restenosis of vertebral artery ostium stents: comparison with conventional angiography.
    Lee YJ; Lim YS; Lim HW; Yoo WJ; Choi BG; Kim BS
    Acta Radiol; 2014 Oct; 55(8):1000-7. PubMed ID: 24107930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis.
    Jing XD; Wei XM; Deng SB; Du JL; Liu YJ; She Q
    Clin Chim Acta; 2015 Jun; 446():248-52. PubMed ID: 25958848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis.
    Saavedra N; Rojas G; Herrera J; Rebolledo C; Ruedlinger J; Bustos L; Bobadilla B; Pérez L; Saavedra K; Zambrano T; Lanas F; Salazar LA
    Biomed Res Int; 2020; 2020():2509039. PubMed ID: 33015157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease.
    Chen BW; Liu JJ; Xing JH; Liu HD; Wei YZ; Xue XF; Gu HP; Tao HL
    Clin Appl Thromb Hemost; 2022; 28():10760296221079334. PubMed ID: 35187964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leihong granule intervened in-stent restenosis after endovascular therapy for lower extremity arterial occlusive diseases: a clinical observation].
    Han B; Ge CQ; Wang LP; Zhang SF; Li HZ; Zhang HG; Zhou CG; Ji GH; Yang Z; Zhang L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Feb; 34(2):153-6. PubMed ID: 24672937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Akyel A; Mendi MA; Oksuz F
    Platelets; 2015; 26(1):48-52. PubMed ID: 24831828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography angiography and myocardial computed tomography perfusion in patients with coronary stents: prospective intraindividual comparison with conventional coronary angiography.
    Rief M; Zimmermann E; Stenzel F; Martus P; Stangl K; Greupner J; Knebel F; Kranz A; Schlattmann P; Laule M; Dewey M
    J Am Coll Cardiol; 2013 Oct; 62(16):1476-85. PubMed ID: 23792193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography.
    Itoh T; Fusazaki T; Kimura T; Oikawa H; Sasou S; Ishikawa Y; Goto I; Komuro K; Nakajima S; Koeda Y; Kaneko K; Nishiyama O; Nakamura M; Morino Y
    Coron Artery Dis; 2015 May; 26(3):201-11. PubMed ID: 25714072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.